333 related articles for article (PubMed ID: 21575000)
1. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
2. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
3. Simple photodynamic therapy dose models fail to predict the survival of MLL cells after HPPH-PDT in vitro.
Weston MA; Patterson MS
Photochem Photobiol; 2009; 85(3):750-9. PubMed ID: 19140895
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
6. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
7. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.
Gillies R; Kollias N; Hasan T; Diddens H
J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464
[TBL] [Abstract][Full Text] [Related]
8. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
10. Photobleaching kinetics of Verteporfin and Lemuteporfin in cells and optically trapped multilamellar vesicles using two-photon excitation.
Tekrony AD; Kelly NM; Fage BA; Cramb DT
Photochem Photobiol; 2011; 87(4):853-61. PubMed ID: 21488879
[TBL] [Abstract][Full Text] [Related]
11. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
12. In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
Casas A; Di Venosa G; Batlle A; Fukuda H
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):931-7. PubMed ID: 12699253
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Guo W; Zhu T
J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells.
Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
Cancer Lett; 2006 Nov; 243(2):281-92. PubMed ID: 16412570
[TBL] [Abstract][Full Text] [Related]
16. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
17. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).
Aveline B; Hasan T; Redmond RW
Photochem Photobiol; 1994 Mar; 59(3):328-35. PubMed ID: 8016212
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells.
Tomioka Y; Kushibiki T; Awazu K
Photomed Laser Surg; 2010 Jun; 28(3):385-90. PubMed ID: 19860571
[TBL] [Abstract][Full Text] [Related]
20. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]